A flavivirus signal peptide balances the catalytic activity of two proteases and thereby facilitates virus morphogenesis

Virology

Volumn 401, Issue 1, 2010, Pages 80-89

  Lobigs, Mario ^a   Lee, Eva ^a   Ng, Mah Lee ^b   Pavy, Megan ^a   Lobigs, Päivi ^a  

^a Biology and Environment   (Australia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Flavivirus; Polyprotein processing; Signal peptide; Virus assembly

Indexed keywords

CAPSID PROTEIN; MEMBRANE PROTEIN; POLYPROTEIN; PROTEINASE; SIGNAL PEPTIDE; STRUCTURAL PROTEIN; VIRUS ENVELOPE PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINE; CELL STRAIN BHK; CELL STRAIN HEPG2; CELL STRAIN K 562; CISTRON; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; ENZYME MECHANISM; FLAVIVIRUS; FLAVIVIRUS INFECTION; HUMAN; HUMAN CELL; INSECT CELL; MOSQUITO; MOUSE; MURRAY VALLEY ENCEPHALITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; REPLICON; SURVIVAL RATE; VERO CELL; VIRUS CAPSID; VIRUS MORPHOGENESIS; VIRUS PARTICLE; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; ANIMALS; CAPSID PROTEINS; CELL LINE; DNA TRANSPOSABLE ELEMENTS; ENCEPHALITIS VIRUS, MURRAY VALLEY; ENCEPHALITIS, ARBOVIRUS; ENDOPEPTIDASES; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PROTEIN SORTING SIGNALS; SERINE ENDOPEPTIDASES; VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; VIRULENCE; VIRUS ASSEMBLY;

FLAVIVIRUS; MIRIDAE; MURRAY VALLEY ENCEPHALITIS VIRUS;

EID: 77950928603     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.02.008     Document Type: Article

References (41)

1. Amberg S.M., Rice C.M. Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing. J. Virol. 1999, 73:8083-8094.
2. Amberg S.M., Nestorowicz A., McCourt D.W., Rice C.M. NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies. J. Virol. 1994, 68:3794-3802.
3. Clark D.C., Lobigs M., Lee E., Howard M.J., Clark K., Blitvich B.J., Hall R.A. In situ reactions of monoclonal antibodies with a viable mutant of Murray Valley encephalitis virus reveal an absence of dimeric NS1 protein. J. Gen. Virol. 2007, 88:1175-1183.
4. Gehrke R., Ecker M., Aberle S.W., Allison S.L., Heinz F.X., Mandl C.W. Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line. J. Virol. 2003, 77:8924-8933.
5. Hall R.A., Kay B.H., Burgess G.W., Clancy P., Fanning I.D. Epitope analysis of the envelope and non-structural glycoproteins of Murray Valley encephalitis virus. J. Gen. Virol. 1990, 71:2923-2930.
6. Harvey T.J., Liu W.J., Wang X.J., Linedale R., Jacobs M., Davidson A., Le T.T., Anraku I., Suhrbier A., Shi P.Y., Khromykh A.A. Tetracycline-inducible packaging cell line for production of flavivirus replicon particles. J. Virol. 2004, 78:531-538.
7. Khromykh A.A., Varnavski A.N., Westaway E.G. Encapsidation of the flavivirus Kunjin replicon RNA by using a complementation system providing Kunjin virus structural proteins in trans. J. Virol. 1998, 72:5967-5977.
8. Khromykh A.A., Varnavski A.N., Sedlak P.L., Westaway E.G. Coupling between replication and packaging of flavivirus RNA: evidence derived from the use of DNA-based full-length cDNA clones of Kunjin virus. J. Virol. 2001, 75:4633-4640.
9. Killian J.A., von Heijne G. How proteins adapt to a membrane-water interface. Trends Biochem. Sci. 2000, 25:429-434.
10. Kofler R.M., Aberle J.H., Aberle S.W., Allison S.L., Heinz F.X., Mandl C.W. Mimicking live flavivirus immunization with a noninfectious RNA vaccine. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:1951-1956.
11. Kuhn R.J., Zhang W., Rossmann M.G., Pletnev S.V., Corver J., Lenches E., Jones C.T., Mukhopadhyay S., Chipman P.R., Strauss E.G., Baker T.S., Strauss J.H. Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell 2002, 108:717-725.
12. Lee E., Lobigs M. Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J. Virol. 2000, 74:8867-8875.
13. Lee E., Lobigs M. E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence. J. Virol. 2008, 82:6024-6033.
14. Lee E., Stocks C.E., Amberg S.M., Rice C.M., Lobigs M. Mutagenesis of the signal sequence of yellow fever virus prM protein: enhancement of signalase cleavage In vitro is lethal for virus production. J. Virol. 2000, 74:24-32.
15. Lee E., Hall R.A., Lobigs M. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. J. Virol. 2004, 78:8271-8280.
16. Lee E., Pavy M., Young N., Freeman C., Lobigs M. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses. Antiviral Res. 2006, 69:31-38.
17. Licon Luna R.M., Lee E., Müllbacher A., Blanden R.V., Langman R., Lobigs M. Lack of both Fas ligand and perforin protects from flavivirus-mediated encephalitis in mice. J. Virol. 2002, 76:3202-3211.
18. Lindenbach B.D., Rice C.M. Flaviviridae: the viruses and their replication. Fields Virology 2001, 991-1042. Lippincott Williams& Wilkins, Philadelphia, PA. 4th ed. D.M. Knipe, P.M. Howley (Eds.).
19. Liu W.J., Sedlak P.L., Kondratieva N., Khromykh A.A. Complementation analysis of the flavivirus Kunjin NS3 and NS5 proteins defines the minimal regions essential for formation of a replication complex and shows a requirement of NS3 in cis for virus assembly. J. Virol. 2002, 76:10766-10775.
20. Lobigs M. Proteolytic processing of a Murray Valley encephalitis virus non-structural polyprotein segment containing the viral proteinase: accumulation of a NS3-4A precursor which requires mature NS3 for efficient processing. J. Gen. Virol. 1992, 73:2305-2312.
21. Lobigs M. Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3. Proc. Natl. Acad. Sci. 1993, 90:6218-6222.
22. Lobigs M., Lee E. Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes. J. Virol. 2004, 78:178-186.
23. Lobigs M., Marshall I.D., Weir R.C., Dalgarno L. Genetic differentiation of Murray Valley encephalitis virus in Australia and Papua New Guinea. Aust. J. Exp. Biol. Med. Sci. 1986, 64(6):571-585.
24. Lobigs M., Marshall I.D., Weir R.C., Dalgarno L. Murray Valley encephalitis virus field strains from Australia and Papua New Guinea: studies on the sequence of the major envelope protein gene and virulence for mice. Virology 1988, 165:245-255.
25. Lobigs M., Mullbacher A., Wang Y., Pavy M., Lee E. Role of type I and type II interferon responses in recovery from infection with an encephalitic flavivirus. J. Gen. Virol. 2003, 84:567-572.
26. Mason P.W., Shustov A.V., Frolov I. Production and characterization of vaccines based on flaviviruses defective in replication. Virology 2006, 351:432-443.
27. Müller U., Steinhoff U., Reis L.F., Hemmi S., Pavlovic J., Zinkernagel R.M., Aguet M. Functional role of type I and type II interferons in antiviral defence. Science 1994, 264:1918-1921.
28. Orlinger K.K., Hoenninger V.M., Kofler R.M., Mandl C.W. Construction and mutagenesis of an artificial bicistronic tick-borne encephalitis virus genome reveals an essential function of the second transmembrane region of protein e in flavivirus assembly. J. Virol. 2006, 80(24):12197-12208.
29. Patkar C.G., Kuhn R.J. Yellow fever virus NS3 plays an essential role in virus assembly independent of its known enzymatic functions. J. Virol. 2008, 82:3342-3352.
30. Pijlman G.P., Kondratieva N., Khromykh A.A. Translation of the flavivirus kunjin NS3 gene in cis but not its RNA sequence or secondary structure is essential for efficient RNA packaging. J. Virol. 2006, 80:11255-11264.
31. Samuel M.A., Diamond M.S. alpha/beta Interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 2005, 79:13350-13361.
32. Scholle F., Girard Y.A., Zhao Q., Higgs S., Mason P.W. trans-Packaged West Nile virus-like particles: infectious properties in vitro and in infected mosquito vectors. J. Virol. 2004, 78:11605-11614.
33. Schrauf S., Mandl C.W., Bell-Sakyi L., Skern T. Extension of flavivirus protein C differentially affects early RNA synthesis and growth in mammalian and arthropod host cells. J. Virol. 2009, 83:11201-11210.
34. Smith T.J., Brandt W.E., Swanson J.L., McCown J.M., Buescher E.L. Physical and biological properties of dengue-2 virus and associated antigens. J. Virol. 1970, 5:524-532.
35. Stocks C.E., Lobigs M. Posttranslational signal peptidase cleavage of the flavivirus C-prM junction, in vitro. J. Virol. 1995, 69:8123-8126.
36. Stocks C.E., Lobigs M. Signal peptidase cleavage at the flavivirus C-prM junction: dependence on the viral NS2B-3 protease for efficient processing requires determinants in C, the signal peptide, and prM. J. Virol. 1998, 72:2141-2149.
37. Stollar V. Studies on the nature of dengue viruses: IV. The structural proteins of type 2 dengue virus. Virology 1969, 39:426-438.
38. Varnavski A.N., Young P.R., Khromykh A.A. Stable high-level expression of heterologous genes in vitro and in vivo by noncytopathic DNA-based Kunjin virus replicon vectors. J. Virol. 2000, 74:4394-4403.
39. von Heijne G. The signal peptide. J. Membr. Biol. 1990, 115:195-201.
40. Yamshchikov V.F., Compans R.W. Regulation of the late events in flavivirus protein processing and maturation. Virology 1993, 192:38-51.
41. Zhang Y., Corver J., Chipman P.R., Zhang W., Pletnev S.V., Sedlak D., Baker T.S., Strauss J.H., Kuhn R.J., Rossmann M.G. Structures of immature flavivirus particles. EMBO J. 2003, 22:2604-2613.